Abstract
Metabolism-associated fatty liver diseases (MAFLDs) are a major global public health concern; however, effective therapies are still not avaiable. MAFLDs are characterized by the excessive accumulation of lipids in hepatic cells, which can be triggered by the activation of nuclear receptors that modulate cellular signaling. Among these, the carbohydrate-responsive element-binding protein …